Edwards Lifesciences Corporation
USD86.00
-1.66 (-1.89%)
CEO
Bernard J. Zovighian
IPO Date
2000-03-27
Sector
Healthcare
Industry
Medical - Devices
Exchange
NYSE
Country
US
Open
$87.63
Prev. Close
$87.66
Day Low
$85.81
Day High
$87.90
52W Low
$72.30
52W High
$89.14
Market Cap
$49.52B
Volume
4.14M
| 10.6 |
| 31 Dec 2023 | FY | 77.0% | 23.4% | 21.1% | 15.0% | 0.10 | 3.38 | 33.0 |
| 31 Dec 2022 | FY | 79.9% | 28.3% | 26.2% | 18.4% | 0.12 | 3.03 | 30.3 |
| 31 Dec 2021 | FY | 76.1% | 28.7% | 25.8% | 17.7% | 0.12 | 3.08 | 53.7 |
| 31 Dec 2020 | FY | 75.4% | 18.8% | 18.0% | 11.4% | 0.15 | 3.46 | 69.0 |
| 31 Dec 2019 | FY | 74.4% | 24.1% | 25.2% | 16.1% | 0.16 | 3.31 | 46.4 |
| 31 Dec 2018 | FY | 74.8% | 19.4% | 23.0% | 13.6% | 0.19 | 2.61 | 44.4 |
| 31 Dec 2017 | FY | 74.5% | 18.1% | 20.8% | 10.9% | 0.35 | 1.81 | 38.2 |
| 31 Dec 2016 | FY | 73.1% | 19.2% | 21.7% | 12.6% | 0.31 | 4.21 | 35.0 |
| 39.1 |
| 30 Jun 2025 | Q2 | 77.6% | 21.5% | 3.1% | 2.4% | 0.07 | 4.68 | 34.8 |
| 31 Mar 2025 | Q1 | 78.7% | 25.3% | 3.5% | 2.7% | 0.07 | 4.45 | 29.7 |
| 31 Dec 2024 | Q4 | 78.9% | 27.8% | 3.9% | 3.0% | 0.07 | 4.18 | 28.3 |
| 30 Sept 2024 | Q3 | 80.6% | 226.7% | 32.2% | 23.7% | 0.07 | 3.46 | 3.2 |
| 30 Jun 2024 | Q2 | 78.5% | 26.4% | 4.9% | 3.6% | 0.09 | 3.71 | 37.1 |
| 31 Mar 2024 | Q1 | 76.0% | 22.0% | 4.9% | 3.6% | 0.09 | 3.75 | 40.3 |
| 31 Dec 2023 | Q4 | 76.7% | 24.1% | 5.6% | 4.0% | 0.10 | 3.38 | 31.2 |
| 30 Sept 2023 | Q3 | 76.3% | 26.0% | 5.8% | 4.1% | 0.10 | 3.28 | 27.3 |